Slim-R Retatrutide 10mg

Keep the sealed, lyophilized vial refrigerated at 2-8°C and protected from direct light. Maintain a documented cold chain during transport and storage; avoid freezing, repeated temperature cycling, and prolonged exposure at room temperature.

Before use, confirm that the vial, seal, lot number, and batch COA are intact. Quarantine the vial if damage, moisture, an unexplained temperature excursion, or a change in appearance is observed.

Reconstitute only under an approved laboratory protocol using the diluent and final concentration specified for the study. Introduce diluent slowly against the vial wall, avoid vigorous shaking, and mix by gentle swirling until the solution is visually uniform.

Label the prepared vial with concentration, preparation date, lot, diluent, and storage conditions. Post-reconstitution stability depends on the validated protocol and diluent; this page does not assign a universal beyond-use period. Use the dose calculator for concentration math and the reconstitution manual for the technical workflow.

Retatrutide remains an investigational compound. Slim-R is supplied strictly as a research material and is not intended for human or animal administration, diagnosis, prevention, or treatment.

Handle only by trained personnel using appropriate PPE, aseptic technique, and institutional chemical-hygiene procedures. Do not use a vial with a compromised seal or uncertain identity. Dispose of unused material and contaminated sharps according to the laboratory's approved waste protocol.

What does the vial contain?
Each vial contains 10mg of lyophilized Retatrutide research material, identified as ZV-R-001.

What is meant by triple agonist?
Retatrutide is studied for activity at GIP, GLP-1, and glucagon receptors. ZENOVA supplies it only for controlled research.

Does this page provide a dose or treatment protocol?
No. The calculator performs research concentration and syringe-volume math only; it does not prescribe treatment or replace an authorized protocol.